Informative Note

Coronavirus: Changes to clinical trials

02/04/2020
Share

INFARMED has published a set of exceptional measures – which will remain in force during the period of risk to public health – to be adopted by sponsors, clinical trial sites, and research teams, to guarantee the safety, protection and rights of clinical trial subjects.

The purpose of this information note is to make known the measures recommended by INFARMED that will be in force during the period of risk to public health.

Downloads

Trending Topics

Coronavirus

Impacts and challenges for businesses in Portugal

PLMJ has created a multidisciplinary team dedicated to analysing the legal and operational challenges that businesses are facing. Our team’s mission is work hand-in-hand with our clients to find the best solutions to mitigate the risks and to relieve some of the pressure they are under.

We have created a Coronavirus Hub to share practical information to help mitigate the risks for companies in Portugal.

Keep up to date

Please note, your browser is out of date.
For a good browsing experience we recommend using the latest version of Chrome, Firefox, Safari, Opera or Internet Explorer.